Biosign Technologies and Dental BioAnalytics have signed an exclusive reseller agreement to sell Biosign products in Canada.
BioAnalytics is positioned to leverage its understanding of, and relationships within, the dental industry to introduce Biosign's pulse-wave-based diagnostic products and services to dentists and their patients across Canada, according to the company.
The terms of the reseller agreement include a minimum sales volume over the term of the agreement, including a five-year growth plan achieving an estimated $10 million in combined revenue. BioAnalytics will have exclusivity of distribution in the Canadian dental market for the Biosign product portfolio for the duration of the agreement.
Copyright © 2010 DrBicuspid.com
